Opinion: AbbVie Best Dividend Stock for an Uncertain Market
In today’s uncertain markets, income-focused investors are weighing reliable cash flow over flashy growth. This piece...
Discover why indices rise or fall, examining earnings, macro data, and policy factors that shape broad market direction.
21,369 articlesIn today’s uncertain markets, income-focused investors are weighing reliable cash flow over flashy growth. This piece...
Planet Fitness posted a robust surge in revenue, but a large investor trimmed a substantial stake. This article break...
If you're building a nest egg that could outlive you, you need dependable income and durable brands. Here are two div...
A bold $1.5 billion investment signals Boston Scientific’s shift into transcatheter aortic valve replacement. Explore...
When a company's CFO sells stock, investors watch closely. This analysis dives into Commvault Systems' sold over trad...
A notable investor doubled down on XPLR Infrastructure after a sharp 42% rise, highlighting the appeal of long-term, ...
As TopBuild (BLD) closes 2025, investors look for how revenue, margins, and backlog shape the 2026 outlook. This arti...
A smaller biotech is stealing headlines in 2026 by delivering strong trial results and strategic collaborations. This...
Investors are scanning for AI leaders beyond the obvious names. This article builds a case for why Broadcom could be ...
Investors targeting higher income are turning to closed-end funds trading at discounts to NAV, seeking a compelling y...
A major AI and cloud deal is flanking SpaceX's IPO, potentially nudging investor sentiment. This article breaks down ...
Zcash has finalized the Ironwood upgrade to patch a vulnerability in the Orchard pool, with activation targeted for l...